Jiang Qixia, Xu Yuanling, Li Xiaohua, Peng Qing, Cai Hui, Wang Jiandong
Department of Outpatient, Jinling Hospital Nanjing 210002, China.
Nanjing University of Chinese Medicine Nanjing, China.
Int J Clin Exp Pathol. 2015 Jan 1;8(1):735-42. eCollection 2015.
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an uncommon extranodal non-Hodgkin lymphoma, with an aggressive course with no well-defined treatment. This article describes a 56-year-old man, treated surgically 7 months earlier for a subcutaneous nodosity near the left axilla, presenting with a progressive inflamed wound, pain, and high fever (39 °C). Treatment with systemic antibiotics and topical anti-inflammatory dressings failed. After 7 months, the patient was diagnosed with SPTCL based on biopsy results and a multidisciplinary consultation. While undergoing systemic chemotherapy with corticosteroid therapy, his wound become more painful, larger, and covered with necrotic tissue. Fifty days after chemotherapy with corticosteroid therapy, his wound became seriously painful and increasingly necrotic. He developed a serious stomachache and abdominal distension, rapidly became comatose, and died. The aim of this case report is to present our experience of the different clinical signs of SPTCL to expedite its early diagnosis in future. We summarize the main clinical characteristics of SPTCL as a rapidly progressing and increasingly painful wound with necrotic tissue, involving a multisystem disorder, which is easily misdiagnosed, responds poorly to corticosteroid and chemotherapy treatments, and has a high mortality rate. The pathological characteristics are early inflammation, advancing to profuse infiltration of the subcutaneous adipose tissues by CD3(+) and/or CD8(+) T-cell lymphoma cells. Clinicians must cooperate with pathologists and oncologists to diagnose this disease as soon as possible and to avoid a misdiagnosis. The use of antibiotic and painkillers should minimize the patient's discomfort and control rapid wound development. Future studies are required to investigate the optimal wound treatment and whether the necrotic tissue should be removed.
皮下脂膜炎样T细胞淋巴瘤(SPTCL)是一种罕见的结外非霍奇金淋巴瘤,病程侵袭性强,尚无明确的治疗方法。本文描述了一名56岁男性,7个月前因左腋窝附近的皮下结节接受了手术治疗,现出现伤口渐进性发炎、疼痛和高热(39℃)。全身抗生素治疗和局部抗炎敷料治疗均无效。7个月后,根据活检结果和多学科会诊,该患者被诊断为SPTCL。在接受全身化疗及皮质类固醇治疗期间,他的伤口疼痛加剧、面积增大,并有坏死组织覆盖。在接受皮质类固醇化疗50天后,他的伤口疼痛严重,坏死加剧。他出现严重的胃痛和腹胀,迅速昏迷并死亡。本病例报告的目的是分享我们对SPTCL不同临床症状的经验,以便在未来加快其早期诊断。我们总结了SPTCL的主要临床特征为伤口迅速进展且疼痛加剧,伴有坏死组织,涉及多系统紊乱,易被误诊,对皮质类固醇和化疗治疗反应不佳,死亡率高。其病理特征为早期炎症,随后CD3(+)和/或CD8(+) T细胞淋巴瘤细胞大量浸润皮下脂肪组织。临床医生必须与病理学家和肿瘤学家合作,尽快诊断此病,避免误诊。使用抗生素和止痛药应尽量减轻患者的不适,并控制伤口的快速发展。未来需要进行研究,以探讨最佳的伤口治疗方法以及是否应清除坏死组织。